Skip to main content
Clinical Trials/NCT04159558
NCT04159558
Unknown
Not Applicable

Development and Evaluation of mHealth Solutions to Monitor and Involve Cardiometabolic Patients in Self-care

Universidad Miguel Hernandez de Elche1 site in 1 country100 target enrollmentApril 24, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypertension
Sponsor
Universidad Miguel Hernandez de Elche
Enrollment
100
Locations
1
Primary Endpoint
Satisfaction with the mobile application assessed by an ad hoc questionnaire
Last Updated
5 years ago

Overview

Brief Summary

To develop, using barcode systems and virtual pillbox (TuMedicina and Alice), an App aimed at patients and carers of patients with cardiometabolic diseases as the main diagnosis, over 45 years of age, who have one or more pathologies and use one or more drugs on a daily basis and to analyze their effectiveness in terms of achieving therapeutic objectives, self-efficacy and self-efficacy in self-care or provision of care (as the case may be), healthy behavior, therapeutic compliance and safe use of medication.

Detailed Description

In order to achieve the objective of this study, an experimental study will carry out on patients with cardiometabolic and respiratory diseases and their caregivers. A participation of 100 patients and 85 caregivers is planned. The aim is for them to use the mobile application developed over three months in order to evaluate their health improvement comparing several clinical and analytic parameters before and after the use of the App, and also evaluating the satisfaction of the participants.

Registry
clinicaltrials.gov
Start Date
April 24, 2018
End Date
October 31, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

José Joaquín Mira

University Professor with a related position as Clinical Psychologist in SNS

Universidad Miguel Hernandez de Elche

Eligibility Criteria

Inclusion Criteria

  • Cardio-metabolic disease, respiratory disease or neurologic disease

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Satisfaction with the mobile application assessed by an ad hoc questionnaire

Time Frame: 3 months

% of participants who were satisfied with the mobile application assessed by an ad hoc questionnaire

Secondary Outcomes

  • Treatment adherence assessed by Morisky Medication Adherence Scale (MMAS)(3 months)

Study Sites (1)

Loading locations...

Similar Trials